CD8A and malaria: Tsujii and co-workers demonstrated that inclusion of α-GalCer (Figure 8) in a malaria vaccine significantly improved protective immunity within two weeks, when compared to the vaccine alone through the activation of iNKT cells leading to secretion of Th1 type cytokines (INF-γ) and CD8+ T cells against the malaria parasite [269].